‘Richest pipeline’ in ASX: Expert names 3 small-cap shares to buy

Ask A Fund Manager: Alto Capital’s Tony Locantro also reveals what his biggest regret in investing is.

| More on:
one hundred dollar notes planted in the ground representing growth asx shares

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Ask A Fund Manager

The Motley Fool chats with the best in the industry so that you can get an insight into how the professionals think. In this edition, Alto Capital investment advisor Tony Locantro talks about why he loves three ASX shares in particular and his biggest regret in investing.

Cut or keep?

The Motley Fool: You’ve mentioned Radiopharm Theranostics Ltd (ASX: RAD) in the past, but it has now dropped about 40% year-to-date. How do you feel about it now? Would you still buy it?

Tony Locantro: Yeah, it was one of the first to lift its head off the canvas during tax loss selling. It was a 60 cent IPO that was poorly supported — fell to a ridiculous low of 13 cents during the last week of tax loss selling. It’s since recovered to 23 cents. 

It is in radiopharmaceuticals. They’ve also added brain tumour technology. It has one of the richest pipelines of any ASX by a technology company, with multiple phase one trials for the remainder of this year and multiple trials next year.

I have bought heavily personally. I am currently underwater and really need to see the stock recover. It has been building a world-class management team, but the stock just fell out of favour as the Nasdaq Composite (INDEXNASDAQ: .IXIC) and US biotech indices underwent a significant correction. 

So the answer to that is yes, it is still great value, but was even better value a few weeks ago… No change to the fundamental view or my faith in management or the company.

The ASX share for a comfortable night’s sleep

MF: If the market closed tomorrow for four years, which stock would you want to hold?

TL: Proteomics International Laboratories Ltd (ASX: PIQ).

I just think from a biotech, it’s got everything going for it. It’s already had a test that’s proven it’s now a sales exercise. They do have the upcoming pipeline and yeah, that’s the one.

There is another one, but you only want one don’t you?

MF: By all means, please tell us.

TL: From a mining perspective, I think Aurumin Ltd (ASX: AUN).

That’s a gold company with ex-key personnel from Northern Star Resources Ltd (ASX: NST). They have purchased the sandstone project. It’s about a 794,000 ounce resource. 

So they purchased a gold resource. They’re looking to grow through exploration and/or acquisition. The company share price has been punished due to drilling for lithium which failed to deliver significant results, combined with tax loss selling. 

I back management to undergo a decent growth profile in those four years. They’re currently undergoing a 15 cent rights issue on a one-for-seven basis with a one-for-one, 25 cent option for existing shareholders.

So I think the company has undergone some issues recently and I think these can be overcome, and I’d certainly back [the] management team to deliver. 

And one of the key aspects, I think, with any gold company that’s looking to grow, sometimes you need to set the weakness to look at picking up assets that the majors don’t want, and that’s how Northern Star was built.

[Northern Star] was a s***ty one-cent company that went to about $15, but during the time that Northern Star grew, the Australian gold index lost two-thirds of its value.

Looking back

MF: Is there a move that you regret from the past? For example, a missed opportunity or buying a stock at the wrong timing or price.

TL: Oh, I regret not being more aggressive with selling.

I think once you start seeing multiples, we all get delusions of grandeur and the dopamine levels increase and we think that the stock’s going to continue running. But history has shown that you need to take profits along the way.

You need to work out if your company would be racing in the Golden Slipper or the Melbourne Cup. Once you can classify your company, then you’re going to take profits in better fashion.

But I always have the regret that I should be more assertive, and assertive with my profit taking.

MF: It’s difficult for the human mind to figure out, isn’t it, knowing when to sell? People find buying a lot easier than selling.

TL: Oh, geez, yeah, yeah, yeah. I’ve had stuff that’s gone 10, 20 times, and a lot of clients won’t sell because they think it’s going higher. Then I try to get them to sell, and then… Yeah. 

But I guess in my sector of the market, they’re exposed to abnormal gains that you wouldn’t get in more conservative stocks.

Motley Fool contributor Tony Yoo has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Small Cap Shares

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Small Cap Shares

‘The smaller you get, the worse the performance has been’: Should ASX small-cap shares be avoided right now?

Is the reward worth the risk?

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop regarding the NRW share price
Small Cap Shares

Experts name 2 exciting small cap ASX shares to buy with huge upside potential

Check out these small cap shares...

Read more »

A young woman lifts her red glasses with one hand as she takes a closer look at news about interest rates rising and one expert's surprising recommendation as to which ASX shares to buy
Small Cap Shares

Goldman Sachs names 2 small cap ASX shares to buy with 80%+ upside

These small cap ASX shares could be in the buy zone...

Read more »

Two kids playing with wooden blocks, symbolising small cap shares and short selling.
Small Cap Shares

2 small-cap ASX shares this fund manager is ‘confident’ about

Ridley is a company that WAM named that it was confident about the outlook.

Read more »

A couple hang off their car looking at the sun rising over the horizon.
Ask a Fund Manager

‘Great long-term investment’: Expert names small-cap ASX share to buy for cheap

Ask A Fund Manager: Cyan Investment Management's Dean Fergie gives his thoughts on three stocks that have halved in price…

Read more »

happy investor, share price rise, increase, up
Small Cap Shares

Analysts name 3 exciting small cap ASX shares with major upside potential

Check out these highly rated small cap ASX shares...

Read more »

Dean Fergie, Cyan Investment Management fund manager
Ask a Fund Manager

‘Extraordinarily cheap’: The ASX share where 77% of its value is cash

Ask A Fund Manager: Cyan Investment Management's Dean Fergie reveals two shares that are absolute bargains at the moment.

Read more »

Dean Fergie, Cyan Investment Management fund manager
Ask a Fund Manager

Why this is the best time to buy small-cap ASX shares: fund manager

Ask A Fund Manager: Cyan Investment Management's Dean Fergie tells how smaller companies have plunged in value this year but…

Read more »